Nuvation Bio (NUVB) News Today $1.94 -0.02 (-1.02%) Closing price 03:58 PM EasternExtended Trading$1.93 -0.01 (-0.52%) As of 06:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Insider Stock Buying Reaches US$720.1k On Nuvation BioMarch 25 at 7:01 PM | uk.finance.yahoo.comNuvation Bio to Present New Nonclinical Data for Taletrectinib at the American Association for Cancer Research Annual Meeting 2025March 25 at 4:45 PM | businesswire.comStock Traders Purchase Large Volume of Nuvation Bio Put Options (NYSE:NUVB)March 22 at 1:13 AM | americanbankingnews.comStock Traders Buy High Volume of Nuvation Bio Put Options (NYSE:NUVB)Nuvation Bio Inc. (NYSE:NUVB - Get Free Report) saw some unusual options trading activity on Thursday. Traders acquired 7,110 put options on the company. This is an increase of 7,800% compared to the typical volume of 90 put options.March 21, 2025 | marketbeat.comIs Nuvation Bio Inc. (NYSE:NUVB) the Most Oversold Penny Stocks to Buy According to Analysts?March 17, 2025 | msn.comBrokerages Set Nuvation Bio Inc. (NYSE:NUVB) Target Price at $8.33March 17, 2025 | americanbankingnews.comAnalyzing Nuvation Bio (NYSE:NUVB) and Arcus Biosciences (NYSE:RCUS)March 17, 2025 | americanbankingnews.comNuvation Bio (NYSE:NUVB) Shares Down 2.5% - Time to Sell?Nuvation Bio (NYSE:NUVB) Shares Down 2.5% - What's Next?March 15, 2025 | marketbeat.comNuvation Bio (NYSE:NUVB) Upgraded to "Strong-Buy" at Jones TradingJones Trading upgraded Nuvation Bio to a "strong-buy" rating in a research note on Tuesday.March 15, 2025 | marketbeat.comNuvation Bio (NYSE:NUVB) Now Covered by Analysts at Jones TradingMarch 15, 2025 | americanbankingnews.comNuvation Bio Inc. (NYSE:NUVB) Receives Consensus Recommendation of "Buy" from AnalystsShares of Nuvation Bio Inc. (NYSE:NUVB - Get Free Report) have been assigned an average recommendation of "Buy" from the six research firms that are presently covering the firm, MarketBeat reports. Six research analysts have rated the stock with a buy rating. The average twelve-month target priceMarch 13, 2025 | marketbeat.comNuvation Bio (NYSE:NUVB) Coverage Initiated by Analysts at Jones TradingJones Trading started coverage on Nuvation Bio in a research report on Wednesday. They issued a "buy" rating and a $10.00 price objective for the company.March 13, 2025 | marketbeat.comJones Trading Initiates Coverage of Nuvation Bio (NUVB) with Buy RecommendationMarch 12, 2025 | msn.comQ1 EPS Estimates for Nuvation Bio Lowered by HC WainwrightNuvation Bio Inc. (NYSE:NUVB - Free Report) - Research analysts at HC Wainwright cut their Q1 2025 earnings estimates for Nuvation Bio in a research report issued to clients and investors on Monday, March 10th. HC Wainwright analyst R. Burns now anticipates that the company will post earnings ofMarch 12, 2025 | marketbeat.comNuvation Bio initiated with a Buy at JonesResearchMarch 11, 2025 | markets.businessinsider.comNuvation Bio price target lowered to $10 from $11 at H.C. WainwrightMarch 10, 2025 | markets.businessinsider.comNuvation Bio (NYSE:NUVB) Shares Gap Down After Analyst DowngradeNuvation Bio (NYSE:NUVB) Shares Gap Down Following Analyst DowngradeMarch 10, 2025 | marketbeat.comNuvation Bio (NYSE:NUVB) Given New $10.00 Price Target at HC WainwrightHC Wainwright lowered their target price on Nuvation Bio from $11.00 to $10.00 and set a "buy" rating for the company in a research note on Monday.March 10, 2025 | marketbeat.comQ1 Earnings Estimate for Nuvation Bio Issued By WedbushNuvation Bio Inc. (NYSE:NUVB - Free Report) - Equities researchers at Wedbush issued their Q1 2026 earnings per share estimates for Nuvation Bio in a report released on Thursday, March 6th. Wedbush analyst D. Nierengarten anticipates that the company will earn ($0.23) per share for the quarter. WMarch 10, 2025 | marketbeat.comNuvation Bio Inc. (NUVB): Among the Best NYSE Penny Stocks to Buy According to AnalystsMarch 9, 2025 | insidermonkey.comNuvation Bio (NYSE:NUVB) Stock Price Up 8% - Still a Buy?Nuvation Bio (NYSE:NUVB) Trading Up 8% - Here's What HappenedMarch 8, 2025 | marketbeat.comNuvation Bio (NYSE:NUVB) Releases Earnings Results, Misses Estimates By $0.01 EPSNuvation Bio (NYSE:NUVB - Get Free Report) issued its earnings results on Thursday. The company reported ($0.15) EPS for the quarter, missing analysts' consensus estimates of ($0.14) by ($0.01).March 7, 2025 | marketbeat.comNuvation Bio files automatic mixed securities shelfMarch 7, 2025 | markets.businessinsider.comWedbush Has Pessimistic View of Nuvation Bio Q3 EarningsNuvation Bio Inc. (NYSE:NUVB - Free Report) - Analysts at Wedbush dropped their Q3 2025 EPS estimates for Nuvation Bio in a research report issued on Monday, March 3rd. Wedbush analyst D. Nierengarten now expects that the company will post earnings of ($0.17) per share for the quarter, down fromMarch 7, 2025 | marketbeat.comNuvation Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business UpdateMarch 6, 2025 | businesswire.comNuvation Bio (NYSE:NUVB) Given "Outperform" Rating at WedbushWedbush reiterated an "outperform" rating and set a $5.00 price objective on shares of Nuvation Bio in a research report on Monday.March 4, 2025 | marketbeat.comNuvation Bio (NYSE:NUVB) Shares Gap Up - What's Next?Nuvation Bio (NYSE:NUVB) Shares Gap Up - What's Next?March 3, 2025 | marketbeat.comRBC bullish on Nuvation as royalty deal, non-dilutive financings remove overhangMarch 3, 2025 | markets.businessinsider.comNuvation Bio Secures Up to $250 Million in Non-Dilutive Financings from Sagard Healthcare PartnersMarch 3, 2025 | businesswire.comNuvation Bio (NUVB) Receives a Buy from RBC CapitalFebruary 27, 2025 | markets.businessinsider.comNuvation Bio (NUVB) to Release Earnings on ThursdayNuvation Bio (NYSE:NUVB) will be releasing earnings before the market opens on Thursday, March 6, Financial Modeling Prep reports.February 27, 2025 | marketbeat.comNuvation Bio to Present at the TD Cowen 45th Annual Health Care ConferenceFebruary 24, 2025 | gurufocus.comKuehn Law Encourages Investors of Nuvation Bio Inc. to Contact Law FirmFebruary 18, 2025 | prnewswire.comNuvation Bio Inc. (NYSE:NUVB) Short Interest Up 14.3% in JanuaryNuvation Bio Inc. (NYSE:NUVB - Get Free Report) saw a large growth in short interest during the month of January. As of January 31st, there was short interest totalling 25,210,000 shares, a growth of 14.3% from the January 15th total of 22,050,000 shares. Currently, 11.0% of the shares of the stock are short sold. Based on an average trading volume of 2,590,000 shares, the days-to-cover ratio is currently 9.7 days.February 17, 2025 | marketbeat.comNuvation Bio: Pending Approval Shot In ROSL+ NSCLS Looks A Major Upside CatalystFebruary 13, 2025 | seekingalpha.comPeapod Lane Capital LLC Invests $1.04 Million in Nuvation Bio Inc. (NYSE:NUVB)Peapod Lane Capital LLC acquired a new stake in shares of Nuvation Bio Inc. (NYSE:NUVB - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 391,745 shares of the company'February 13, 2025 | marketbeat.comNuvation Bio executive departs after key milestonesFebruary 12, 2025 | msn.comKuehn Law Encourages Investors of Nuvation Bio Inc. to Contact Law FirmFebruary 12, 2025 | investing.comNuvation Bio launches EAP for lung cancer drug taletrectinibFebruary 3, 2025 | msn.comNuvation Bio Announces Expanded Access Program in the U.S. for Taletrectinib in Advanced ROS1-positive Non-Small Cell Lung CancerFebruary 3, 2025 | finance.yahoo.comNuvation Bio begins EAP for taletrectinib in US for advanced ROS1 + NSCLCFebruary 3, 2025 | markets.businessinsider.comNuvation Bio Announces Expanded Access Program in the U.S. ...February 3, 2025 | gurufocus.comWith 46% stake, Nuvation Bio Inc. (NYSE:NUVB) seems to have captured institutional investors' interestJanuary 30, 2025 | finance.yahoo.comHC Wainwright Cuts Earnings Estimates for Nuvation BioNuvation Bio Inc. (NYSE:NUVB - Free Report) - Equities research analysts at HC Wainwright dropped their Q3 2025 earnings estimates for Nuvation Bio in a report issued on Thursday, January 23rd. HC Wainwright analyst R. Burns now anticipates that the company will earn ($0.16) per share for the quaJanuary 27, 2025 | marketbeat.comAssenagon Asset Management S.A. Sells 309,176 Shares of Nuvation Bio Inc. (NYSE:NUVB)Assenagon Asset Management S.A. lessened its stake in Nuvation Bio Inc. (NYSE:NUVB - Free Report) by 70.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 129,363 shares of the company's stock after selling 309,176 shares during the perioJanuary 26, 2025 | marketbeat.comJPMorgan Chase & Co. Increases Position in Nuvation Bio Inc. (NYSE:NUVB)JPMorgan Chase & Co. boosted its holdings in shares of Nuvation Bio Inc. (NYSE:NUVB - Free Report) by 479.1% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 442,913 shares of the company's stock after pJanuary 26, 2025 | marketbeat.comNuvation Bio (NYSE:NUVB) Trading Down 3.8% - Here's WhyNuvation Bio (NYSE:NUVB) Trading Down 3.8% - Here's WhyJanuary 24, 2025 | marketbeat.comNuvation Bio price target raised to $11 from $10 at H.C. WainwrightJanuary 24, 2025 | markets.businessinsider.comNuvation Bio (NYSE:NUVB) Given New $11.00 Price Target at HC WainwrightHC Wainwright increased their price objective on Nuvation Bio from $10.00 to $11.00 and gave the company a "buy" rating in a report on Thursday.January 23, 2025 | marketbeat.comNuvation Bio Inc. (NYSE:NUVB) Short Interest UpdateNuvation Bio Inc. (NYSE:NUVB - Get Free Report) was the target of a large increase in short interest during the month of December. As of December 31st, there was short interest totalling 20,940,000 shares, an increase of 35.9% from the December 15th total of 15,410,000 shares. Approximately 9.1% of the company's shares are sold short. Based on an average daily trading volume, of 2,320,000 shares, the short-interest ratio is currently 9.0 days.January 16, 2025 | marketbeat.com Remove Ads Get Nuvation Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for NUVB and its competitors with MarketBeat's FREE daily newsletter. Email Address NUVB Media Mentions By Week NUVB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NUVB News Sentiment▼0.670.68▲Average Medical News Sentiment NUVB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NUVB Articles This Week▼53▲NUVB Articles Average Week Remove Ads Get Nuvation Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for NUVB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NewAmsterdam Pharma News HUTCHMED News MoonLake Immunotherapeutics News ImmunityBio News Beam Therapeutics News Vericel News Mirum Pharmaceuticals News Edgewise Therapeutics News Centessa Pharmaceuticals News Kymera Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:NUVB) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuvation Bio Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuvation Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NUVB Stock Free NUVB Stock Alerts